Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal (CANVAS-R): A randomized, placebo-controlled trial.
Neal, Bruce MB ChB, PhD *,1,2,3,4; Perkovic, Vlado MBBS, PhD 1,5; Matthews, David R. DPhil, BM, BCh 6; Mahaffey, Kenneth W. MD 7; Fulcher, Greg MD 5; Meininger, Gary MD 8; Erondu, Ngozi MD, PhD 8; Desai, Mehul MD 8; Shaw, Wayne DSL 8; Vercruysse, Frank MD 9; Yee, Jacqueline MS, RD 8; Deng, Hsiaowei MS 8; de Zeeuw, Dick MD, PhD 10; on behalf of the CANVAS-R Trial Collaborative Group
Diabetes, Obesity & Metabolism.
19(3):387-393, March 2017.
(Format: HTML, PDF)